You are here » Home » Companies » Company Overview » Concord Drugs Ltd

Concord Drugs Ltd.

BSE: 538965 Sector: Health care
NSE: N.A. ISIN Code: INE858L01010
BSE 00:00 | 18 Sep 17.30 -0.40
(-2.26%)
OPEN

16.95

HIGH

17.95

LOW

16.95

NSE 05:30 | 01 Jan Concord Drugs Ltd
OPEN 16.95
PREVIOUS CLOSE 17.70
VOLUME 2980
52-Week high 19.67
52-Week low 11.68
P/E 39.32
Mkt Cap.(Rs cr) 15
Buy Price 17.25
Buy Qty 200.00
Sell Price 17.75
Sell Qty 200.00
OPEN 16.95
CLOSE 17.70
VOLUME 2980
52-Week high 19.67
52-Week low 11.68
P/E 39.32
Mkt Cap.(Rs cr) 15
Buy Price 17.25
Buy Qty 200.00
Sell Price 17.75
Sell Qty 200.00
Filter:

Concord Drugs Ltd. (CONCORDDRUGS) - Financial Overview

Particulars ( cr) 2019 2018 2017
Net Sales 48.08 51.80 57.49
Operating Profit 3.74 4.91 5.59
Other Income 0.09 0.14 0.09
Interest 1.59 1.88 2.36
Depreciation 1.71 2.40 2.58
Profit Before Tax 0.44 0.63 0.65
Tax 0.03 0.31 0.49
Profit After Tax 0.41 0.32 0.16
 
Share Capital 7.86 7.86 7.24
Reserves 15.29 11.46 11.75
Net Worth 23.15 19.32 18.99
Loans 12.54 16.39 16.21
Gross Block 30.84 30.79 28.52
Investments 0.00 0.00 0.00
Cash 0.18 0.06 0.23
Debtors 48.43 71.17 15.65
Net Working Capital 23.55 22.20 21.56
 
Operating Profit Margin (%) 7.78 9.48 9.72
Net Profit Margin (%) 0.85 0.62 0.28
Earning Per Share (Rs) 0.52 0.41 0.22
Dividend (%) 0.00 0.00 0.00
Dividend Payout 0.00 0.00 0.00